(Q46335608)

21 December 2017

title

DXA-based hip structural analysis of once-weekly bisphosphonate-treated postmenopausal women with low bone mass (English)

1 reference

21 December 2017

author name string

S L Bonnick

1

1 reference

21 December 2017

T J Beck

2

1 reference

21 December 2017

F Cosman

3

1 reference

21 December 2017

M C Hochberg

4

1 reference

21 December 2017

H Wang

5

1 reference

21 December 2017

A E de Papp

6

1 reference

21 December 2017

language of work or name

English

0 references

publication date

2 October 2008

1 reference

21 December 2017

Osteoporosis International

published in

1 reference

21 December 2017

volume

20

1 reference

21 December 2017

issue

6

1 reference

21 December 2017

page(s)

911-921

1 reference

21 December 2017

https://scigraph.springernature.com/pub.10.1007/s00198-008-0762-4

exact match

0 references

cites work

Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents

1 reference

12 December 2020

Finite element models predict in vitro vertebral body compressive strength better than quantitative computed tomography

1 reference

12 December 2020

Effects of teriparatide [rhPTH (1-34)] treatment on structural geometry of the proximal femur in elderly osteoporotic women

1 reference

12 December 2020

Prediction of femoral fracture load using automated finite element modeling

1 reference

12 December 2020

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

12 December 2020

Contribution of raloxifene and calcium and vitamin D3 supplementation to the increase of the degree of mineralization of bone in postmenopausal women

1 reference

12 December 2020

Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy

1 reference

12 December 2020

Structural effects of raloxifene on the proximal femur: results from the multiple outcomes of raloxifene evaluation trial

1 reference

12 December 2020

Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk

1 reference

12 December 2020

Effects of Intermittent Parathyroid Hormone Administration on Bone Mineralization Density in Iliac Crest Biopsies from Patients with Osteoporosis: A Paired Study before and after Treatment

1 reference

12 December 2020

Femoral neck BMD is a strong predictor of hip fracture susceptibility in elderly men and women because it detects cortical bone instability: the Rotterdam Study

1 reference

12 December 2020

Comparison of Weekly Treatment of Postmenopausal Osteoporosis with AlendronateVersusRisedronate Over Two Years

1 reference

12 December 2020

Effect of hormone replacement, alendronate, or combination therapy on hip structural geometry: a 3-year, double-blind, placebo-controlled clinical trial

1 reference

12 December 2020

Discrimination between cases of hip fracture and controls is improved by hip structural analysis compared to areal bone mineral density. An ex vivo study of the femoral neck.

1 reference

12 December 2020

Five years of treatment with risedronate and its effects on bone safety in women with postmenopausal osteoporosis

1 reference

12 December 2020

Measuring the structural strength of bones with dual-energy X-ray absorptiometry: principles, technical limitations, and future possibilities

1 reference

12 December 2020

Change in lumbar spine BMD and vertebral fracture risk reduction in teriparatide-treated postmenopausal women with osteoporosis

1 reference

12 December 2020

Geometric structure of the femoral neck measured using dual-energy x-ray absorptiometry

1 reference

12 December 2020

Predicting femoral neck strength from bone mineral data. A structural approach

1 reference

12 December 2020

Effects of denosumab on bone mineral density and bone turnover in postmenopausal women

1 reference

12 December 2020

A method to assess the proportion of treatment effect explained by a surrogate endpoint

1 reference

12 December 2020

Non-invasive measurement of long bone cross-sectional moment of inertia by photon absorptiometry.

1 reference

12 December 2020

Prediction of hip fractures from pelvic radiographs: the study of osteoporotic fractures. The Study of Osteoporotic Fractures Research Group

1 reference

12 December 2020

Antifracture efficacy of antiresorptive agents are related to changes in bone density.

1 reference

12 December 2020

Structure of the Femoral Neck in Hip Fracture: Cortical Bone Loss in the Inferoanterior to Superoposterior Axis

1 reference

12 December 2020

Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: a randomized double-blind study

1 reference

12 December 2020

Estimation of distal radius failure load with micro-finite element analysis models based on three-dimensional peripheral quantitative computed tomography images.

1 reference

12 December 2020

Extending DXA beyond bone mineral density: understanding hip structure analysis

1 reference

12 December 2020

1 reference

12 December 2020

Quantitative computed tomography estimates of the mechanical properties of human vertebral trabecular bone

1 reference

12 December 2020

Influence of estrogen therapy at conventional and high doses on the degree of mineralization of iliac bone tissue: a quantitative microradiographic analysis in postmenopausal women

1 reference

12 December 2020

In vivo short-term precision of hip structure analysis variables in comparison with bone mineral density using paired dual-energy X-ray absorptiometry scans from multi-center clinical trials.

1 reference

12 December 2020

Alendronic acid produces greater effects than risedronic acid on bone density and turnover in postmenopausal women with osteoporosis : results of FACTS -international.

1 reference

12 December 2020

Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women

1 reference

12 December 2020

Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs

1 reference

12 December 2020

Prediction of incident hip fracture risk by femur geometry variables measured by hip structural analysis in the study of osteoporotic fractures

1 reference

12 December 2020

Contributions of bone density and structure to fracture risk assessment in men and women

1 reference

12 December 2020

Effect of risedronate on hip structural geometry: a 1-year, double-blind trial in chemotherapy-induced postmenopausal women

1 reference

12 December 2020

Comparison of quantitative computed tomography-based measures in predicting vertebral compressive strength

1 reference

12 December 2020

A comparison of the effect of alendronate and risedronate on bone mineral density in postmenopausal women with osteoporosis: 24-month results from FACTS-International.

1 reference

12 December 2020

Contribution of hip strength indices to hip fracture risk in elderly men and women.

1 reference

12 December 2020

Effects of denosumab on the geometry of the proximal femur in postmenopausal women in comparison with alendronate

1 reference

12 December 2020

Effect of femoral rotation on bone mineral density measurements with dual energy X-ray absorptiometry

1 reference

12 December 2020

Structural and biomechanical basis of sexual dimorphism in femoral neck fragility has its origins in growth and aging

1 reference

12 December 2020

10.1007/S00198-008-0762-4

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017